Objectives: Antimicrobial stewardship (AMS) programmes have been developed with the intention of reducing inappropriate and unnecessary use of antimicrobials, while improving the quality of patient care and locally helping prevent the development of antimicrobial resistance. An important aspect of AMS programmes is the qualitative assessment of prescribing through antimicrobial prescribing surveys (APS), which are able to provide information about the prescribing behaviour within institutions. Owing to lack of standardization of audit tools and the resources required, qualitative methods for the assessment of antimicrobial use are not often performed. The aim of this study was to design an audit tool that was appropriate for use in all Australian hospitals, suited to local user requirements and included an assessment of the overall appropriateness of the prescription.
Introduction
There is a well-established link between antimicrobial usage and development of antimicrobial resistance, 1 -3 leading to strategies to improve antimicrobial prescribing. 4 -6 Reasons for inappropriate prescribing include lack of education, misinterpretation of results, prescribing etiquette and medication errors, the consequences of which may increase morbidity, mortality and healthcare costs. 7 -9 Antimicrobial stewardship (AMS) programmes have been developed to improve the quality of patient care by reducing inappropriate and unnecessary use of antimicrobials.
In 2011 the Australian Commission on Safety and Quality in Health Care (ACSQHC) published recommendations for AMS programmes to be established in all Australian hospitals 10 and in 2013 AMS was included as a hospital accreditation criterion in the Australian National Safety and Quality Health Service Standards. 11 All hospitals are now required to audit antimicrobial prescribing; 12 consequently there is a need to determine the most appropriate tools for auditing, with an opportunity to provide comparative analysis between hospital types while collecting national data.
Antimicrobial consumption data, often reported in DDDs, 13 monitor trends in drug consumption, but do not provide a comprehensive analysis of prescribing or explain the reasons for changes, 14 which may result in the misinterpretation of data. 15 More detailed antimicrobial prescribing surveys (APS), including point prevalence surveys (PoPS) and period prevalence surveys (PePS), provide superior data on prescribing behaviour, 16 thereby identifying targets for quality improvement and assisting in the evaluation of interventions of AMS programmes. 17 There are published tools designed for such audits, comparing data across institutions, nationally and internationally. 16 -18 The Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA) determined areas for targeted interventions in Sweden, which is thought to have contributed to a reduction of total antibiotic use and potentially limited the spread of multiresistant organisms. 19 The European Surveillance of Antibiotic Consumption (ESAC) is a collaboration across European countries designed to provide a standardized method for performing antimicrobial PoPS, based on the STRAMA methodology. This collaboration chose not to include qualitative assessments due to concerns regarding the validity. 17 After trialling a published audit tool 17 across six public metropolitan hospitals in 2009 and 2010, participants reported that it lacked qualitative information about the appropriateness of the prescription 20 and modification of the tool was required to suit local user requirements. In Australia, access to expert staff involved in AMS (infectious diseases physicians, clinical microbiologists and antimicrobial pharmacists) is limited to metropolitan hospitals and 76% of public hospitals lie outside these metropolitan centres. 21 This creates a challenging situation, as existing tools are designed for expert users, whereas in the Australian context there is a requirement for a tool suitable for non-expert auditors.
The aim of this study was to design an antimicrobial prescribing audit tool that was suitable for use in all Australian hospitals and by data collectors with a wide range of clinical antimicrobial prescribing experience, while being practical, generalizable and facilitating, where possible, qualitative assessments including appropriateness.
Methods

Part 1-development of the APS tool
The APS tool was designed by a multidisciplinary group of researchers within Melbourne Health, Victoria, comprising infectious diseases physicians, clinical microbiologists and pharmacists specializing in AMS, using local and international tools, expert opinion and clinician feedback. Focusing on key performance indicators and avoiding extraneous detail, it was developed for consistent data interpretation across all hospital settings (metropolitan, regional, rural, private) and by various auditors (doctors, pharmacists, infection control practitioners, ward nurses).
Fields included the admitting specialty type, details of the antimicrobial prescription, indication for each prescription, documented allergies and microbiology results. Key areas of interest for benchmarking were adequate documentation of indication, compliance with prescribing guidelines (including antimicrobial choice, dose, route and duration if prolonged) and whether surgical prophylaxis was continued for .24 h. Finally, the auditors were requested to make an assessment of the overall 'appropriateness' of each prescription as either 'appropriate', 'inappropriate' or 'not assessable', taking into account all of the clinical information available. The option 'not assessable' was available if there were no relevant clinical guidelines for the documented indication, the patient was too complex or there was not enough clinical information to guide assessment. See the Supplementary data available at JAC Online for the 2011 APS tool.
Inter-rater reliability and validity were determined through trials at the Royal Melbourne Hospital, Victoria, by auditors from different health profession backgrounds and with differing levels of experience in AMS. Charts were assessed and compared with those of 'experts', consisting of the research group that designed the tool.
Part 2-first pilot study and evaluation
In November 2011, coinciding with Antimicrobial Awareness Days throughout Australia, North America and Europe, 22 ,23 a pilot APS was conducted to assess the usability and generalizability of the tool, ensuring that it could be used by a range of end users to achieve their specified goals with efficiency and satisfaction. Recruitment of hospitals focused on diversity, ranging from metropolitan to rural hospitals, selected through personal communication with professional contacts. A toolkit was distributed to all participants, including instructions on the use of the tool and three worked training scenarios, to assist in the assessment of appropriateness of the prescription, followed by a webinar to explain how to use the tool and to answer any questions.
All inpatients admitted at 8 a.m. on the day of the audit were eligible for inclusion, with the exception of those in psychiatry wards, day stay wards or outpatient clinics. Participants were able to choose which patients to audit, with the audit being performed over one to several days as a PoPS, a selection of wards or specialties, or as a PePS with data collected over several weeks. A minimum of 30 patient's data was required, as per a previous study protocol. 7 Medication charts were reviewed to capture all antimicrobials prescribed as at 8 a.m. of the morning of the audit and any once-only prescriptions given within the previous 24 h. All antimicrobials from Anatomical Therapeutic Chemical (ATC) group 'J' 13 were audited: antibacterial, antimycobacterial, antiviral, antifungal and antiparasitic. The documented indication, comorbidities and other relevant information were obtained from the patient's medical records and any relevant radiology, microbiological or other pathology data were also documented. Auditors were instructed not to review patients or discuss the prescription with the treating team or ward staff.
It was advised that the assessment of 'compliance with guidelines' and 'appropriateness' should involve a multidisciplinary team, consisting of a physician and a pharmacist or infection control practitioner. Collected data were entered into an online SurveyMonkey w data entry portal and both the individual and de-identified, combined data were returned to the submitting hospital in graphical and spreadsheet form using Excel (Microsoft w ). Evaluation of the tool was conducted via a web-based questionnaire, followed by a teleconference, assessing the demographics of the participating hospitals, the personnel completing the APS, the participant's experience and opinion of ease of use of the tool, the time taken to collect, analyse and enter the data, problems encountered and usefulness of the data.
Part 3-second pilot study
Following reviewer feedback, the APS tool was revised to reflect the requirements of the respondents, being more flexible, with essential fields that could be collected regardless of expertise. Further optional fields were included, which could be collected by hospitals wishing to perform a more in-depth survey, shown as shaded fields on the 2012 APS form in the Supplementary data. A second pilot APS was performed in November 2012 coinciding with the inaugural Australian Antimicrobial Awareness Week. 24 A revised toolkit including new instructions and a set of 13 training scenarios was sent to participants, with an unchanged audit protocol. Recruitment was again through professional contacts and also using AMS and infection control networks. into the SurveyMonkey w portal and all hospital data were de-identified before any combined data were returned.
Statistics
All results were reported descriptively and no statistical analysis was performed.
Results
Inter-rater reliability and validity testing
From the initial assessment at the Royal Melbourne Hospital, there was a high rate of inter-rater reliability between auditors (,5% difference between seven assessors auditing eight common patients). Importantly, high validity was achieved, with 95% concordance with the assessment of appropriateness between the assessors and the expert group (53 out of 56 audit forms).
Although this was only a small and simple assessment of interrater reliability and validity, the research group believed that it was sufficient to progress to a pilot study.
First pilot study
Thirty-two hospitals participated in the 2011 APS (median 335 beds; range 20 -924 beds), with 2523 individual prescriptions documented, the demographics of which are displayed in Table 1 . These were from five states: Queensland, New South Wales, Victoria, Tasmania and South Australia. Combined data from this survey are displayed in Table 2 .
Evaluation survey
The evaluation survey was completed by 31 out of the 32 participating hospitals and the focus group discussion was attended by 15 auditors. Figure 1 outlines some of the key results from the Comments from the auditors confirmed that the tool was well accepted amongst a diverse range of hospitals and, importantly, the majority of auditors found the tool easy to use. They also reported willingness to participate in further audits and to share de-identified data for benchmarking purposes. Key recommendations included the need for greater flexibility in patient sampling and data collected and the ability to directly enter data into an online database. Key challenges reported included inadequate staffing and resources to administer the APS. Many respondents reported that the training scenarios better equipped them to judge the appropriateness of the prescription, although there were still some complex cases where expert advice to assist in the evaluation of appropriateness was desirable.
Second pilot study-2012 APS
There were 85 participating hospitals from every Australian state and territory (median hospital size 123 beds; range 4 -909 beds), with 5185 individual prescriptions documented, the demographics of which are displayed in Table 1 . There was no formal evaluation survey following this second pilot study, but auditors were encouraged to contact the coordinating team with any problems or suggestions. Many positive comments were received, with no major problems reported. The key combined data results from this survey are presented in Table 2 . Nine of the larger public hospitals chose to use their own spreadsheet for data entry rather than using the common web-based database; therefore their data were not included in the analysis.
Data from the 2012 survey described the most commonly prescribed ATC level 4 antimicrobial groups 25 for the patients audited; penicillins with b-lactamase inhibitors (namely amoxicillin/ clavulanic acid) were the most common antimicrobials used, followed by first-generation cephalosporins (namely cefazolin) and then third-generation cephalosporins (namely ceftriaxone). The most common indications were surgical prophylaxis, followed by community-acquired pneumonia and then urinary tract infections. These data are also consistent with the 2011 survey and previously published local and international studies 16,17,26 -29 and are displayed in Figures 2 and 3 . As the top 15 indications and ATC level 4 antimicrobial groups prescribed for the 2011 survey were similar to those from the 2012 survey, they are not displayed.
As these were pilot studies with known selection bias from the method of hospital recruitment and patient selection, and due to the difficulty in extracting data from the SurveyMonkey w platform, subanalysis of these data was not attempted.
Discussion
It was encouraging that the two surveys had a wide range of hospital sizes and remoteness classifications, including private hospitals, establishing that this APS tool was generalizable to a wide range of hospital types. Feedback from the evaluation survey and the focus group discussion provided invaluable information on how the APS tool was utilized and perceived. It was mainly positive with constructive suggestions about possible improvements, including the ability to perform data collection electronically and to have flexibility in how they performed the audit. As the purpose of such audits is to provide meaningful feedback to prescribers and executives regarding prescribing practices, this should be by the most influential methods known to effect change. Currently this is believed to be when delivered through senor clinicians and accompanied by measureable performance indicators with actionable strategies for improvement. 30 To assist with this process, graphical representation of key performance indicators from the APS were provided as an effective feedback system, suitable for visual presentations for executives or clinical and education meetings.
14 This aspect was greatly appreciated by the participants, especially the smaller, more poorly resourced hospitals.
The survey identified several areas as possible targets for quality improvement. Seventy-eight per cent of antimicrobial prescriptions had the indication for their use documented in the medical notes; the benchmark for this criterion set by other groups has been Each form took on average 5-10 min per patient to collect, assess and enter data 91% of hospitals performed the survey on 1 day 87% of auditors thought it had the right amount of detail 88% of hospitals would like to collect the data electronically in future 94% of hospitals were willing to perform the survey again (2 undecided) 85% of hospitals would like to perform a survey every 6-12 months 41% of hospitals performed the survey as a hospital-wide PoPS 55% would perform the survey as a hospital-wide PoPS in future 58% thought staffing issues would be a barrier to performing the survey in future 100% of hospitals would be happy to provide de-identified data for benchmarking purposes 17 Accurate documentation of indication is important for prescription review and to promote streamlining, de-escalation and ceasing of antimicrobials by clinical teams, pharmacists and nursing staff. 31 Surgical prophylaxis was the most commonly documented indication in both surveys. Orders for .24 h constituted 5% and 9% of all audited prescriptions in the 2011 and 2012 audits, respectively. Importantly though, 59% of all surgical prophylaxis prescriptions were for .24 h. There is an obvious need for review of these prescribing practices, as international benchmarks of 100% for surgical prophylaxis prescriptions being ,24 h have been suggested. 17 This presents itself as an area to target further with more in-depth audit into prescribing protocols and practices. These data were very similar to those identified from STRAMA and ESAC studies performed throughout Europe, 17, 19 demonstrating that there is the potential to compare data internationally for these key performance indicators.
Australia is fortunate in that it has a nationally endorsed set of prescribing guidelines for the use of antimicrobials (Therapeutic Guidelines: Antibiotic), 32 providing the ability to audit compliance James et al.
with these guidelines, or with local guidelines where available. An average of 28% of prescriptions audited were reported to be noncompliant with guidelines, highlighting the need to target improvement in this domain.
Although not all hospitals chose to assess the appropriateness of the prescriptions in the 2012 survey, those that did [69 (91%)] felt that this was achievable for the majority of prescriptions. Auditors utilized the category 'not assessable' when the prescription was deemed too complicated for an accurate assessment or if there was not enough documented information available within the medical notes to make an informed decision. There was also demand for improved definitions for appropriateness that could be applied consistently, particularly when staff with differing levels of experience were conducting the audit. Accurate assessment of compliance with guidelines and appropriateness were seen as major limitations to the survey. Therefore, for future surveys, the research group plan to refine the definition of appropriateness and create a dedicated online database with training modules incorporated to assist with this assessment. It is also apparent that lack of standardized prescribing guidelines will limit international comparisons for these assessments.
Despite these issues, the majority of auditors were prepared to perform the survey every 6 -12 months and there was no objection for de-identified data being used for benchmarking purposes. It is important to understand though that data collection and processing can be very time-consuming, especially where limited resources are available, and a more sustainable solution, such as regular smaller prescriptive surveys rather than infrequent hospital-wide surveys, may be required, 17, 31 thereby allowing greater flexibility with data entry depending on the needs and resources available and at a time suitable to each facility.
An online database will be developed, allowing increased facility participation, reducing selection bias and improving the robustness of the data collected to allow for further detailed subanalysis. This will for the first time provide comprehensive information about the appropriateness of prescribing practices nationally. All hospitals in Australia will be eligible to enter data and receive individualized reports. It is also expected that some level of de-identified data will be made available for benchmarking between like hospitals and annual reports on antimicrobial prescribing will be generated. There is also the intention to provide individual facility representation against national minimum standards for several key performance indicators; this has previously been shown to improve performance. 33 Formal inter-rater reliability and validity testing will be performed to ensure that there is consistency in data collection and assessment across hospital types and auditor professions, and define areas requiring greater assistance and training.
It takes time and effort to develop an audit tool that is suitable for different AMS practitioners in a wide range of hospital settings. By involving the end users in the design and evaluation, we have been able to provide a practical and relevant tool for metropolitan, regional and rural hospitals and the private sector. AMS is now a requirement for all Australian hospitals as part of new accreditation criteria, 11 with the monitoring and evaluation of antimicrobial use an essential component. This carefully considered and constructed APS tool should allow all Australian hospitals to be involved in quantitative and qualitative auditing of their antimicrobial prescribing practices and become involved in national and potentially international benchmarking studies.
These pilot surveys have identified elements required for a national APS and determined key performance indicators to use in benchmarking like facilities. Importantly, they have also demonstrated that a qualitative assessment of antimicrobial prescribing is achievable, although the process and criteria for this need to be more clearly defined.
